- Home
- NCNO vs GH Comparison
NCNO vs GH Comparison
Compare NCNO & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCNO
- GH
- Stock Information
- Founded
- NCNO 2011
- GH 2011
- Country
- NCNO United States
- GH United States
- Employees
- NCNO N/A
- GH N/A
- Industry
- NCNO Computer Software: Prepackaged Software
- GH Medical Specialities
- Sector
- NCNO Technology
- GH Health Care
- Exchange
- NCNO Nasdaq
- GH Nasdaq
- Market Cap
- NCNO 3.8B
- GH 3.0B
- IPO Year
- NCNO 2020
- GH 2018
- Fundamental
- Price
- NCNO $29.00
- GH $25.81
- Analyst Decision
- NCNO Buy
- GH Strong Buy
- Analyst Count
- NCNO 12
- GH 17
- Target Price
- NCNO $38.00
- GH $39.31
- AVG Volume (30 Days)
- NCNO 1.4M
- GH 2.2M
- Earning Date
- NCNO 08-27-2024
- GH 11-04-2024
- Dividend Yield
- NCNO N/A
- GH N/A
- EPS Growth
- NCNO N/A
- GH N/A
- EPS
- NCNO N/A
- GH N/A
- Revenue
- NCNO $506,125,000.00
- GH $643,810,000.00
- Revenue This Year
- NCNO $23.84
- GH $27.01
- Revenue Next Year
- NCNO N/A
- GH $18.30
- P/E Ratio
- NCNO N/A
- GH N/A
- Revenue Growth
- NCNO 13.64
- GH 26.20
- 52 Week Low
- NCNO $27.13
- GH $15.81
- 52 Week High
- NCNO $37.48
- GH $37.04
- Technical
- Relative Strength Index (RSI)
- NCNO 31.31
- GH 43.49
- Support Level
- NCNO $29.67
- GH $23.48
- Resistance Level
- NCNO $30.52
- GH $26.85
- Average True Range (ATR)
- NCNO 0.76
- GH 1.15
- MACD
- NCNO -0.42
- GH -0.13
- Stochastic Oscillator
- NCNO 3.45
- GH 40.31
About NCNO nCino Inc.
Ncino Inc is a provider of cloud-based software for financial institutions. Its software solution digitizes, automates, and streamlines inefficient and complex processes & workflow and utilizes data analytics & artificial intelligence that enables financial institutions to onboard new clients, make loans and manage the entire loan life cycle, open deposits, and other accounts and manage regulatory compliance. It also offers professional services, including configuration & implementation, training, and advisory services. Ncino generates the majority of its revenue from subscription services. The company caters to financial institutions, enterprise banks, regional banks, community banks, and credit unions. The vast majority of its revenue comes from the United States.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.